M. Sayitoglu Et Al. , "Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia," Journal of International Medical Research , vol.37, no.4, pp.1018-1028, 2009
Sayitoglu, M. Et Al. 2009. Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia. Journal of International Medical Research , vol.37, no.4 , 1018-1028.
Sayitoglu, M., Haznedaroǧlu, I. C., Hatirnaz, O., Erbilgin, Y., Aksu, S., Koca, E., ... Adiguzel, C.(2009). Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia. Journal of International Medical Research , vol.37, no.4, 1018-1028.
Sayitoglu, M. Et Al. "Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia," Journal of International Medical Research , vol.37, no.4, 1018-1028, 2009
Sayitoglu, M. Et Al. "Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia." Journal of International Medical Research , vol.37, no.4, pp.1018-1028, 2009
Sayitoglu, M. Et Al. (2009) . "Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia." Journal of International Medical Research , vol.37, no.4, pp.1018-1028.
@article{article, author={M. Sayitoglu Et Al. }, title={Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia}, journal={Journal of International Medical Research}, year=2009, pages={1018-1028} }